TELL ME MORE
ABOUT THIS CLINICAL TRIAL for ECZEMA
A Phase 2a Study of the Effects of an investigational medicine in Adults with Moderate to Severe Atopic Dermatitis – 18-75 years
Clinical Trial for Atopic Dermatitis (Eczema)
Study Location(s): Owensboro, KY
Atopic dermatitis, the most common type of eczema, results from an overactive immune system that causes the skin barrier to become dry and itchy. While the exact cause of eczema is unknown, researchers do know that people develop eczema because of an interaction between genes and environmental triggers.
Atopic dermatitis affects more than 9.6 million children and about 16.5 million adults in the United States alone. The hallmark symptom is itching, but the itching can cause other symptoms such as rashes, pain, and poor sleep caused by itching. People with atopic dermatitis can also experience the breaking down of the skin barrier, which can weaken the immune system. This skin condition can appear anywhere on their body and oozing rashes can form as a result. (source: National Eczema Association)
There is no cost to participate. Volunteers receive no cost investigational medicine and follow-up care. No insurance needed. Time and travel compensation up to $1375 may be available for participation.